Click to open contact form.
Your Global Partners in the Business of Innovation

Yael Baratz

  • Senior Partner & Chair of the Corporate & Licensing Group
  • Tel Aviv
Yael advises global leading entities and influential individuals on a broad range of corporate and commercial matters.


Yael Baratz is a Senior Partner and Chair of the Corporate & Licensing Group at Pearl Cohen’s Tel Aviv office. With expertise in the full range of cross border corporate transactions, particularly in the high-tech and biotech industries, Yael advises global leading entities and influential individuals on a broad range of corporate and commercial matters, including cross border mergers and acquisitions, internal and external investment rounds, technology licensing and other collaborations and non-dilutive financing (including grants from the Israel Innovation Authority of the Israeli Ministry of Economy, previously known as the Office of the Chief Scientist or OCS). Yael is considered as one of the leading lawyers in Israel on the subject of university licensing and counsels many of Israel’s leading research institutions. Yael also has vast experience in international joint ventures and in representing foreign contractors in teaming with local companies in bidding and carrying out large public infrastructure projects. Yael’s clients include Israeli and foreign publicly traded tech and bio companies, university and hospital technology transfer offices, large infrastructure contractors and start-ups.

Yael is considered a prime resource for legal advice and an expert on cross border transactions. She has been named by global directories, including Who’s Who Legal and LMG Life Sciences as a leading attorney in the Life Sciences sector.

Furthermore, Yael served for several years as a judge on the National Disciplinary Tribunal of the Israel Bar Association, which hears appeals, and currently serves as Co-Chair of the Israel Bar Association’s Science and Technology Committee.

Yael advised an R&D company on a collaborative research, option and licensing agreement with a medtech company involving technology for the detection of the cell origin of tissue-specific DNA.
Yael has been ranked as a Recommended Global Leader for Life Sciences - Transactional 2019
Led jointly by Doron Latzer and Yael Baratz, the corporate group has complementary strengths in cross-border investment and M&A and high-value commercial and joint venture agreements.